Free Trial

Datametrex AI (CVE:DM) Hits New 52-Week Low - Here's What Happened

Datametrex AI logo with Computer and Technology background
Remove Ads

Datametrex AI Limited (CVE:DM - Get Free Report)'s stock price hit a new 52-week low during trading on Monday . The stock traded as low as C$0.09 and last traded at C$0.09, with a volume of 6876 shares trading hands. The stock had previously closed at C$0.09.

Datametrex AI Stock Performance

The firm has a market cap of C$48.32 million, a P/E ratio of -1.14 and a beta of 2.59. The company has a debt-to-equity ratio of 554.49, a quick ratio of 2.44 and a current ratio of 0.40. The company's 50 day moving average is C$0.05 and its 200 day moving average is C$0.02.

About Datametrex AI

(Get Free Report)

Datametrex AI Limited engages in the collecting, analyzing, and presenting structured and unstructured data using machine learning and artificial intelligence in Canada and South Korea. The company operates through two segments, AI and Technology and Health Care. It offers health security businesses, including concierge medical services, and telemedicine services; Imagine Health consisting of integrated medical centre, pharmacy, and ancillary services; physician consultation and medical professional services; and sale of prescription drugs and over-the-counter products.

See Also

Should You Invest $1,000 in Datametrex AI Right Now?

Before you consider Datametrex AI, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Datametrex AI wasn't on the list.

While Datametrex AI currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads